TABLE 2.
Main immune cells in heart failure.
| Immune cells | Functions | Potential therapeutic targets from animal studies |
| Macrophages | Elevated CCR2+MHCIIhighLy6c+ macrophages in myocardium could secrete inflammatory cytokines and contribute to ventricular dysfunction | CCR2–CCL2 signaling axis |
| Mast cells | Attenuate left ventricular remodeling and promote cardiac dysfunction | Mast cell depletion |
| Neutrophils | Destructive at acute stage and protective at chronic stage | Annexin A1 |
| Natural killer cells | Release cytokines and modulate immune system | |
| Dendritic cells | Protective at acute stage and destructive at chronic stage | |
| CD4+ T cells | TH1 cells are mainly proinflammatory | |
| TH2 cells are mainly profibrosis | ||
| TH17 cells contribute to cardiac hypertrophy and promote adverse cardiac remodeling | ||
| B cells | Induce direct myocardial injury, produce inflammatory cytokines, and antibodies | B-cell depletion |